Full-Time

APU Shift Leader

Apu 1 D

Posted on 9/24/2025

Nemera

Nemera

1,001-5,000 employees

Designs, develops, manufactures drug delivery devices

No salary listed

Wheeling, IL, USA

In Person

Category
Operations & Logistics (1)
Requirements
  • High School Diploma or equivalent
  • 3 years injection molding experience required
  • Ability to lift 50 lbs.
  • Ability to stand, sit and walk up to 90% of shift
  • Ability to bend, stoop, reach, push, pull, grab, and climb as needed.
Responsibilities
  • Support and maintain all policies of the company including but not limited to ISO Standards, Health and Safety Requirements, Continuous Improvement as well as standard work procedures
  • Monitor customer specification sheets and appropriate processing sheets
  • Ensure responses to corrective action requests are accurate, complete and timely
  • Supervise and maintain housekeeping, 5S standards and Autonomous Maintenance activities
  • Supervise and assist in mold set ups and start-ups
  • Coordinate production reports
  • Delegate responsibilities to technicians and other employees, when applicable
  • Organize meetings for all employees to facilitate communication and resolve issues
  • Coordinate all employee training
  • Maintain attendance records
  • Take necessary corrective or disciplinary actions with subordinates as necessary
  • Document all employee conflicts or problems and forward to the Production Manager or Human Resources
  • Daily scheduling of operators
  • Coordinate the issuing of tool repair request and maintenance work orders
  • Supervise all production employees
  • Other duties as assigned
Desired Qualifications
  • 2 + years of leadership and or supervisory experience strongly preferred
  • Mechanical aptitude
  • Ability to work on Microsoft Office, Word, Excel
  • Basic SAP knowledge
  • Knowledge of inspection technicians

Nemera designs, develops, and manufactures drug delivery devices for pharmaceutical and biotech companies, spanning ophthalmic, nasal, buccal, parenteral, dermal, and inhalation routes. The devices are used to administer medicines and are developed and manufactured in collaboration with customers, often through co-development and customized production in a B2B model. It stands out by offering an end-to-end range of delivery solutions across multiple administration routes, supported by global manufacturing facilities and a wide distribution network. Its goal is to enable safer, more convenient self-administered therapies by providing scalable devices and related design and manufacturing services to partners.

Company Size

1,001-5,000

Company Stage

Acquired

Total Funding

$1.2B

Headquarters

La Verpillière, France

Founded

2014

Simplify Jobs

Simplify's Take

What believers are saying

  • Rising demand for diabetes and obesity injection pens drives La Verpillière expansion, starting production 2027.
  • New Szczecin hall strengthens leadership in GLP-1 drug market for obesity therapies.
  • Milfra acquisition in June 2021 expands footprint in Brazil's gynecology and urology markets.

What critics are saying

  • SteadyMed's Releev One captures Symbioze market share in GLP-1 delivery within 12-18 months.
  • Ypsomed's dose accuracy wins Novo Nordisk contracts, undercutting La Verpillière capacity in 6-12 months.
  • SHL Medical's DAI platform displaces Nemera's devices in Eli Lilly obesity pens within 12-24 months.

What makes Nemera unique

  • Nemera specializes in drug delivery devices across ophthalmic, nasal, buccal, parenteral, dermal, and inhalation routes.
  • Launched Symbioze wearable injector in October 2021 for self-administration needs.
  • Introduced UniSpray unidose nasal system for emergency systemic drug delivery.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

Nemera
Jul 21st, 2025
Nemera expands production capacity in Szczecin to strengthen leadership in GLP-1 drug market

Nemera, a global leader in the design, development, and manufacturing of drug delivery device solutions, has inaugurated a new production hall at its state-of-the-art facility in Szczecin, Poland.

Nemera
Oct 11th, 2023
Nemera extends manufacturing capabilities in North America

That's the new space Nemera has acquired to set up the next state-of-the-art manufacturing facility.

Jobmatch Ohio
Sep 15th, 2023
Printer Operator- Off Shift

In May of 2014, Rexam sold the plastics business and the Berlin Plant was acquired by Nemera, naming the prescription products business as Centor Inc.

The Real Deal
Jul 25th, 2023
Panattoni gets $26M for Vernon Hills industrial building

French medical device manufacturer Nemera is expanding its industrial footprint in suburban Chicago.

Nemera
Mar 10th, 2023
Nemera reinforces commitment to sustainability with first integrated ESG report

Nemera France SAS is thrilled to announce the publication of its first integrated ESG report.

INACTIVE